Paper · 42423293
Optimizing postoperative prognostication in duodenal adenocarcinoma: a multicenter study with external validation.
Gu Z and 17 others. Oncologist, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Optimizing postoperative prognostication in duodenal adenocarcinoma: a multicenter study with external validation. Papers, record 42423293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42423293
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Optimizing postoperative prognostication in duodenal adenocarcinoma: a multicenter study with external validation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Duodenal Neoplasms | Major topic |
| Adenocarcinoma | Major topic |
| Humans | |
| Prognosis | |
| Female | |
| Nomograms | |
| Male | |
| Middle Aged | |
| Aged |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CIFMS; 2022-I2M-1-010 | Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences | PubMed | ||
| 2025HY0116 | Medical and Health Science Program of Zhejiang Province | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 42,426,561 | The role of adjuvant chemotherapy in small bowel adenocarcinomas. | https://conductscience.org/library/papers/42426561 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,536,196 | Surgical Outcome After Pancreatoduodenectomy for Duodenal Adenocarcinoma Compared with Other Periampullary Cancers: A Nationwide Audit Study. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/36536196 | PubMed |
| 2 | 28,040,257 | The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. | Surgery | 2017 | https://conductscience.org/library/papers/28040257 | PubMed |
| 3 | 33,407,508 | Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33407508 | PubMed |
| 4 | 17,981,197 | Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). | Surgery | 2007 | https://conductscience.org/library/papers/17981197 | PubMed |
| 5 | 27,732,711 | Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival. | JAMA Surg | 2017 | https://conductscience.org/library/papers/27732711 | PubMed |
| 6 | 22,167,476 | Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22167476 | PubMed |
| 7 | 17,629,996 | Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. | Surgery | 2007 | https://conductscience.org/library/papers/17629996 | PubMed |
| 8 | 34,774,726 | STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. | Int J Surg | 2021 | https://conductscience.org/library/papers/34774726 | PubMed |
| 9 | 39,261,238 | Clinicopathologic features and surgery-related outcomes of duodenal adenocarcinoma: A multicenter retrospective study. | Surgery | 2024 | https://conductscience.org/library/papers/39261238 | PubMed |
| 10 | 31,630,251 | Trends in incidence of small bowel cancer according to histology: a population-based study. | J Gastroenterol | 2020 | https://conductscience.org/library/papers/31630251 | PubMed |
1 to 10 of 39
See all 39 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,426,561 | The role of adjuvant chemotherapy in small bowel adenocarcinomas. | Oncologist | 2026 | https://conductscience.org/library/papers/42426561 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42423293
GET https://conductscience.org/api/papers/v1/42423293/references?page=2